Published in BMJ on November 06, 2004
Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) (2011) 1.12
Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study. Pharmacotherapy (2009) 0.82
Drug-induced prolongation of the QT interval. N Engl J Med (2004) 10.96
The QT interval. Prog Cardiovasc Dis (2001) 2.22
Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine. Arzneimittelforschung (1982) 0.94
Lofexidine and clonidine in moderate essential hypertension. Clin Pharmacol Ther (1981) 0.92
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) (2006) 4.23
A memory retrieval-extinction procedure to prevent drug craving and relapse. Science (2012) 4.04
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry (2009) 2.95
Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol (2005) 2.32
Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav (2003) 1.94
Methadone maintenance and breastfeeding in the neonatal period. Pediatrics (2008) 1.86
The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? Addict Behav (2002) 1.74
The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology (2005) 1.68
Cocaine craving and use during daily life. Psychopharmacology (Berl) (2009) 1.62
Tobacco, cocaine, and heroin: Craving and use during daily life. Addict Behav (2009) 1.56
Effects of stress on decision-making deficits in formerly heroin-dependent patients after different durations of abstinence. Am J Psychiatry (2011) 1.50
Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics (2005) 1.49
A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am J Drug Alcohol Abuse (2009) 1.49
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol (2009) 1.48
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther (2004) 1.46
Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry (2011) 1.44
The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) (2003) 1.43
Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl) (2011) 1.37
Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol (2006) 1.34
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) (2007) 1.32
Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav (2005) 1.31
A factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Nicotine Tob Res (2003) 1.28
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend (2004) 1.26
Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev (2006) 1.22
Daily life hour by hour, with and without cocaine: an ecological momentary assessment study. Psychopharmacology (Berl) (2010) 1.21
Are We There Yet? Feasibility of Continuous Stress Assessment via Wireless Physiological Sensors. ACM BCB (2015) 1.12
Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) (2011) 1.12
Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J Hum Lact (2007) 1.12
Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Depend (2008) 1.11
Gender and stimulus difference in cue-induced responses in abstinent heroin users. Pharmacol Biochem Behav (2007) 1.09
Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers. Pharmacol Biochem Behav (2007) 1.08
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend (2003) 1.08
Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. J Subst Abuse Treat (2006) 1.08
Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Depend (2002) 1.06
Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol (2007) 1.06
Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry (2010) 1.05
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J (2006) 1.01
Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol (2002) 1.00
Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology (Berl) (2009) 0.99
Puffing behavior during the smoking of a single cigarette in tobacco-dependent adolescents. Nicotine Tob Res (2009) 0.97
Marriage and relationship closeness as predictors of cocaine and heroin use. Addict Behav (2008) 0.96
A dose response study of cognitive behavioral therapy in cocaine abusers. J Subst Abuse Treat (2002) 0.95
Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course. Drug Alcohol Depend (2011) 0.95
Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users. J Appl Behav Anal (2008) 0.94
Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. J Subst Abuse Treat (2007) 0.94
Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients. Addict Behav (2007) 0.94
Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients. Addict Behav (2006) 0.93
Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method. Drug Alcohol Depend (2007) 0.90
Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender. Drug Alcohol Depend (2005) 0.90
Psychosocial stress after reactivation of drug-related memory impairs later recall in abstinent heroin addicts. Psychopharmacology (Berl) (2008) 0.90
Time spent with friends who smoke and quit attempts among teen smokers. Addict Behav (2004) 0.90
Progression to daily smoking: is there a gender difference among cessation treatment seekers? Subst Use Misuse (2007) 0.89
EEG absolute power during extended cocaine abstinence. J Addict Med (2007) 0.89
Heart rate and blood pressure responses to tobacco smoking among African-American adolescents. J Natl Med Assoc (2004) 0.88
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol (2006) 0.87
Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management. J Appl Behav Anal (2008) 0.87
A meta-analysis of Chinese herbal medicine in treatment of managed withdrawal from heroin. Cell Mol Neurobiol (2008) 0.86
Effects of high-dose intravenous buprenorphine in experienced opioid abusers. J Clin Psychopharmacol (2004) 0.86
Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Subst Use Misuse (2005) 0.86
Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug Alcohol Depend (2013) 0.85
Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug Alcohol Depend (2008) 0.85
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem (2007) 0.85
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Am J Addict (2014) 0.84
Quit attempts among African American teenage smokers seeking treatment: gender differences. Prev Med (2004) 0.84
Cannabis withdrawal in chronic cannabis users with schizophrenia. J Psychiatr Res (2012) 0.84
A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management. Drug Alcohol Depend (2012) 0.84
Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat (2005) 0.84
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict (2013) 0.84
Circadian alteration in neurobiology during 30 days of abstinence in heroin users. Biol Psychiatry (2009) 0.84
Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroin. Neuropsychopharmacology (2002) 0.83
Do noncontingent vouchers increase drug use? Exp Clin Psychopharmacol (2003) 0.83
Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study. Pharmacotherapy (2007) 0.83
A focus-group study on spirituality and substance-user treatment. Subst Use Misuse (2010) 0.83